<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Pak J Med Sci</journal-id><journal-id journal-id-type="iso-abbrev">Pak J Med Sci</journal-id><journal-title-group><journal-title>Pakistan Journal of Medical Sciences</journal-title></journal-title-group><issn pub-type="ppub">1682-024X</issn><issn pub-type="epub">1681-715X</issn><publisher><publisher-name>Professional Medical Publications</publisher-name><publisher-loc>Pakistan</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">27882012</article-id><article-id pub-id-type="pmc">5103124</article-id><article-id pub-id-type="publisher-id">PJMS-32-1152</article-id><article-id pub-id-type="doi">10.12669/pjms.325.9960</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Individualized supervised resistance training during nebulization in
adults with cystic fibrosis</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Shaw</surname><given-names>Ina</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1"/></contrib><contrib contrib-type="author"><name><surname>Kinsey</surname><given-names>Janine E.</given-names></name><xref ref-type="aff" rid="aff2">2</xref></contrib><contrib contrib-type="author"><name><surname>Richards</surname><given-names>Roxanne</given-names></name><xref ref-type="aff" rid="aff3">3</xref></contrib><contrib contrib-type="author"><name><surname>Shaw</surname><given-names>Brandon S.</given-names></name><xref ref-type="aff" rid="aff4">4</xref></contrib></contrib-group><aff id="aff1"><label>1</label>Prof. Ina Shaw, PhD. Department of Sport &#x00026; Movement
Studies, University of Johannesburg, Republic of South Africa</aff><aff id="aff2"><label>2</label>Ms. Janine E. Kinsey, B.Hons. Department of Sport &#x00026;
Movement Studies, University of Johannesburg, Republic of South Africa</aff><aff id="aff3"><label>3</label>Mrs. Roxanne Richards, B.Hons. Department of Sport &#x00026;
Movement Studies, University of Johannesburg, Republic of South Africa</aff><aff id="aff4"><label>4</label>Prof. Brandon S. Shaw, PhD. Department of Sport &#x00026;
Movement Studies, University of Johannesburg, Republic of South Africa</aff><author-notes><corresp id="cor1"> Correspondence: Prof Brandon S. Shaw, PhD Professor &#x00026;
Vice-Dean: Faculty of Health Sciences, University of Johannesburg, Doornfontein,
Johannesburg, Republic of South Africa. E-mail: <email xlink:href="brandons@uj.ac.za">brandons@uj.ac.za</email></corresp></author-notes><pub-date pub-type="ppub"><season>Sep-Oct</season><year>2016</year></pub-date><volume>32</volume><issue>5</issue><fpage>1152</fpage><lpage>1157</lpage><history><date date-type="received"><day>10</day><month>2</month><year>2016</year></date><date date-type="accepted"><day>29</day><month>7</month><year>2016</year></date></history><permissions><copyright-statement>Copyright: &#x000a9; Pakistan Journal of Medical
Sciences</copyright-statement><copyright-year>2016</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0"><license-p><!--CREATIVE COMMONS-->This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/3.0">http://creativecommons.org/licenses/by/3.0</ext-link>), which permits
unrestricted use, distribution, and reproduction in any medium, provided the
original work is properly cited.</license-p></license></permissions><abstract><sec id="st1"><title>Background &#x00026; Objective:</title><p>Since dyspnea limits exercise adherence and intensity in cystic fibrosis (CF)
patients, engaging in resistance training (RT), which causes less dyspnea than
other exercise modalities, while using nebulizers could not only overcome this
barrier, but also enhance long-term adaptations to treatment. The objective of
this study was to examine the effects of RT during nebulization on spirometry,
anthropometry, chest wall excursion, respiratory muscle strength and
health-related quality of life (HRQOL).</p></sec><sec id="st2"><title>Methods:</title><p>Fourteen male and female CF patients were assigned to a four-week, 20-minute,
5-day per week proof-of-concept RT group (RTG) (n=7) or non-exercising control
group (CON) (n=7), with 3 CON patients later dropping out of the study. Patients
performed whole body exercises for 3 sets of 10 reps using resistance bands, since
such bands have previously demonstrated a greater effect on functional exercise
capacity than conventional RT in lung patients.</p></sec><sec id="st3"><title>Results:</title><p>The RTG displayed significant (p&#x02264;0.05) increases in FEV<sub>1</sub>,
FEV<sub>1</sub>/FVC, latissimusdorsi strength, pectoralis major clavicular
portion strength, pectoralis major sternocostal portion strength and emotional and
digestion HRQOL domains, while decreasing pectoralis minor strength on the left
and social, body image and respiration HRQOL domains.</p></sec><sec id="st4"><title>Conclusion:</title><p>This small scale proof-of-concept investigation demonstrates the multiple and
simultaneous benefits of RT during nebulization in CF patients. The improvements
in pulmonary measures are particularly promising especially since this study only
made use of a four-week experimental period. This study provides an important
alternative, time-saving treatment for the CF patient that does not add to the
treatment burden of CF patients.</p></sec></abstract><kwd-group><title>KEY WORDS</title><kwd>Cardiopulmonary Disease</kwd><kwd>Health-Related Quality of Life</kwd><kwd>Lung Disease</kwd><kwd>Strength Training</kwd><kwd>Weight Training</kwd></kwd-group></article-meta></front><body><sec sec-type="intro" id="sec1-1"><title>INTRODUCTION</title><p>Cystic fibrosis (CF) is a multi system disease that primarily affects the pulmonary
system and pancreas. Pulmonary abnormalities arising from CF include excess production
of viscous mucus secretions, which may obstruct airways, leading to subsequent declines
in pulmonary function.<xref rid="ref1" ref-type="bibr">1</xref> While CF has no cure,
the goal of treatments for CF include the preventing and controlling of lung infections,
the loosening and removing thick, sticky mucus from the lungs and improvements in
physical functioning and quality of life (QOL).</p><p>However, from infancy, CF patients must be subjected to all kinds of stressful and/or
time-consuming treatments, such as inhalation therapy, mist tents, suction machines,
physical rehabilitation and nebulization.<xref rid="ref2" ref-type="bibr">2</xref> While
treatments have greatly improved in recent years, standards of care for patients with CF
have been defined largely on the basis of best practice, and are given to treatment
regimens showing low chronic pulmonary infection rates, greatest patient longevity, and
least patient morbidity.<xref rid="ref3" ref-type="bibr">3</xref> However, it is
becoming more critical that treatments be scientifically proven and since CF patients
have multiple treatments in a day, timesaving in the development of treatments is
crucial.</p><p>Taking the primary goal of CF treatment into account, nebulizers are commonly used for
the treatment of CF and other respiratory diseases and use oxygen, compressed air or
ultrasonic power to break up medical solutions and suspensions into small aerosol
droplets that can be directly inhaled. The therapeutic effectiveness of an inhaled drug
depends on a number of factors, but in particular how much bypasses the oropharynx and
deposits in the lungs.<xref rid="ref4" ref-type="bibr">4</xref> While inertial impaction
occurs in the upper airways and in the first few generations of bronchi, distally, as
the cross-sectional area of the airways increases, airflow velocity decreases and
becomes more laminar and deposition of the inhaled submicronic particles becomes
dependant on gravitational sedimentation<xref rid="ref4" ref-type="bibr">4</xref>,
provided that they are not exhaled.<xref rid="ref5" ref-type="bibr">5</xref> As such, it
may prove important for CF patients to engage in techniques that slow and deepen tidal
breath, thus increasing dwell time.</p><p>One such technique that may prove effective is resistance training (RT). This is because
RT as an exercise modality makes use of Valsalva manoeuvres which not only increases the
depth, but also slows the rate of tidal volume and thus limits the chances of expelling
the inhaled submicronic particles. The concurrent use of RT would not only increase the
efficacy of nebulization, but may itself provide additional benefits to the CF patient
without resulting in an additional time burden on CF patients. In turn, the use of
nebulization during RT could reduce exercise-induced hypoxemia and increase exercise
tolerance, oxygen supply and adaptations<xref rid="ref6" ref-type="bibr">6</xref> and
thus overcome the primary reason that many CF patients abstain from exercise.
Interestingly, since dyspnoea limits the exercise adherence and intensity, RT, which
causes less dyspnoea<xref rid="ref7" ref-type="bibr">7</xref>, it could be an
alternative mode of exercise for CF patients. The aim of this study was to examine
the long-term effects of RT during nebulization on spirometry, anthropometry, chest
wall excursion, respiratory muscle strength and health-related quality of life
(HRQOL).</p></sec><sec sec-type="methods" id="sec1-2"><title>METHODS</title><p>A convenience sample of 14 CF male and female patients, aged between 16 and 33 years,
attending the Cystic Fibrosis Clinic at the Charlotte Maxeke Johannesburg Academic
Hospital in Johannesburg, South Africa that were approved by their attending specialists
for participation in the study. They were not engaging in any regular exercise program
were assigned to either a resistance training group (RTG) (n=7) or non-exercising
control group (CON) (n=7) for this small scale proof-of-concept investigation. Prior to
participation, all patients gave written, informed consent to participate in the
study.</p><p>The study was approved by the Research Ethics Committee of the University of
Johannesburg (AEC01-69-2014), the University of Witwatersrand Human Research Ethics
Committee (Medical) (M140628) and the director of Clinical Services Charlotte Maxeke
Johannesburg Academic Hospital. Patients were required to be free from any acute
respiratory infection symptoms or pulmonary exacerbations, current or previous
participation within the last six months in exercise therapy or changes in any therapy
four weeks prior to the evaluations. Patients were excluded from participation in the
study if they presented with relative and absolute contraindications to exercise or
presented with any clinically significant abnormalities that could have interfered with
the assessments. All patients underwent identical pre- and post-test measurements.</p><p>Since the life expectancy of CF patients in developing countries is much less than their
counterparts in developed countries, the present study made use of simple measuring
procedures. This is because since CF is not a priority for governments in developing
countries, there are not only limited resources available, but a lack of trained health
professionals for the care of specific problems in CF patients.<xref rid="ref8" ref-type="bibr">8</xref></p><p>The present study made use of the Cystic Fibrosis Questionnaire-Revised (CFQ-R) which is
a disease-specific health-related qualify of life (HRQOL) measure assessing (1)
physical, (2) emotional, (3) social, (4) body image, (5) eating, (6) treatment burden,
(7) respiration and (8) digestion domains.<xref rid="ref9" ref-type="bibr">9</xref></p><p>Body mass and stature were measured to the nearest 0.1 kg and 0.01 meters (m),
respectively using a scale and standard wall-mounted stadiometer (Mettler DT Digitol,
Mettler-Toledo AG, Ch-8606 GreiFensee, Switzerland) with patients wearing minimal
clothing and no shoes. Skinfolds of the triceps, subscapular, suprailiac, paraumbilicus,
frontal thigh and medial calf were measured to the closest 0.2 millimeters (mm) using a
Harpenden skinfold caliper (Rosscraft Industries, Canada). Percentage body fat was
calculated using the equations of Withers et al.<xref rid="ref10" ref-type="bibr">10</xref>, fat mass by multiplying body mass with percentage body fat which was
divided by 100, lean mass as total body mass in kg subtracted by fat mass in kg and body
mass index (BMI) by dividing body mass by stature squared (body
mass/stature<sup>2</sup>) and expressed as kilograms per square meter
(kg.m<sup>-2</sup>).<xref rid="ref11" ref-type="bibr">11</xref></p><p>Spirometry of all patients were performed with patients upright and wearing a nose clip
so that no air could escape during the test. A mouthpiece was inserted into the turbine
sensor (Quark PFTergo, Cosmed, Rome, Italy), where the patients were blowing into. The
FVC test required each patient to expire as hard and as fast as possible and had to
complete the cycle by inspiring as hard and rapidly as possible. The tests were
performed at least three times with the largest value recorded being utilized in the
final analysis.<xref rid="ref12" ref-type="bibr">12</xref></p><p>Since it is essential for CF patients to maintain and improve mobility of the chest
wall, abdominal and thoracic dimensions and kinematics measurements were used as an
evaluative method for diaphragmatic breathing excursion to quantify possible alterations
in thoracic capacity and abdominal and chest wall compliance as achieved by all
expiratory and inspiratory muscles.<xref rid="ref13" ref-type="bibr">13</xref> By
measuring the abdomen and thorax with a nondistendable measuring tape in centimetres to
the nearest 0.1 cm during rest, maximal inspiration and expiration over the second
intercostal space, xiphoid process and mid-point between the xiphoid process and
umbilicus, a competency in diaphragmatic breathing can be demonstrated by a reduction in
rib cage excursion. This evaluation was used to quantify possible alterations in
thoracic capacity and possibly abdominal and chest wall compliance as achieved by all
inspiratory and expiratory muscles.<xref rid="ref13" ref-type="bibr">13</xref></p><p>The present study assessed the respiratory muscles for maximal effort due to the major
limitation of spirometry in its poor sensitivity to detect moderate inspiratory muscle
weakness<xref rid="ref14" ref-type="bibr">14</xref>, the strength of the accessory
respiratory muscles, and specifically the latissimus dorsi, pectoralis major
(sternocostal and clavicular portions), pectoralis minor and abdominals, were manually
tested using an aneroid sphygmomanometer (Alpk2 Sphygmomanometer, Japan) for the
lattisimus dorsi, pectoralis major (clavicular portion), pectoralis major (sternocostal
portion), pectoralis minor muscles, held by the evaluator at the test position and the
difference achieved by the patients from a baseline setting of 20 millimetres mercury
(mmHg) and the seven stage sit-up test for abdominal muscles.<xref rid="ref13" ref-type="bibr">13</xref>,<xref rid="ref15" ref-type="bibr">15</xref>,<xref rid="ref16" ref-type="bibr">16</xref></p><p>As CF patients display reduced exercise tolerance and complaints of fatigue and dyspnea,
even after minimal exertion, the present study utilised a supervised 20-minute, 5 days
per week (Monday through Friday) progressive RT program for four weeks<xref rid="ref18" ref-type="bibr">18</xref> with elasticated resistance bands
(Thera-Band&#x000ae;) targeting large muscle groups, since such bands have previously
demonstrated a greater effect on functional exercise capacity than conventional
resistance training in COPD patients.<xref rid="ref18" ref-type="bibr">18</xref>
Patients performed 3 sets of 10 reps for (1) seated chest press, (2) squat, (3) lateral
raises, (4) bicep curls, (5) plank, (6) standing high rows, (7) shrugs, (8)
latissimusdorsi pull downs and (9) rhomboid squeezes with rest periods of 30 seconds or
less.<xref rid="ref19" ref-type="bibr">19</xref> While different band tensions were
utilised for different exercises with greater resistance required for larger muscle
groups, regardless of the colour (resistance) of the band, all strength training
exercises were performed with the bands elongated to at least 70%.<xref rid="ref20" ref-type="bibr">20</xref> This protocol was designed to ensure that all
patients trained with a consistent and progressive amount of resistive force. In an
attempt to reduce exercise-induced hypoxemia and increase exercise tolerance, oxygen
supply and adaptations, the exercise program was during the patients&#x02019; nebulizing
times.<xref rid="ref6" ref-type="bibr">6</xref> In addition, this RT and nebulization
protocol was performed concurrently in an attempt to relieve the time-burden of
treatments on CF patients. The CON patients were instructed to maintain their normal
daily activities and medication usage throughout the four-week experimental period and
received no prescribed exercise program.</p><p>Data were analysed using the Statistical Package of Social Sciences (SPSS) Version 20
(IBM Corporation, Armonk, NY). Statistical analysis consisted of basic statistics to
determine baseline and post-training means and standard deviations. T-tests were
utilised to determine if a significant change occurred within groups from pre- to
post-test and between groups. A probability value of &#x02264; 0.05 was considered
significant.</p></sec><sec sec-type="results" id="sec1-3"><title>RESULTS</title><p>While 14 male and female CF patients were assigned to the four-week treatment protocol,
3 CON patients were not included in the final study due to their failure to attend the
post-test evaluations.</p><p>Results indicated significantly (p&#x02264;0.05) increased FEV<sub>1</sub> (p=0.021),
FEV<sub>1</sub>/FVC (p=0.046), latissimusdorsi strength on the left (p=0.022) and
right (p=0.001), pectoralis major: clavicular portion strength on the left (p=0.042) and
right (p=0.038), pectoralis major: sternocostal portion strength on the left (p=0.030)
and right (p=0.025) and emotional (p=0.011) and digestion (p=0.018) HRQOL domains on the
CFQ-R in the RTG (<xref ref-type="table" rid="T1">Table-I</xref>). A significantly
decreased pectoralis minor strength on the left (p=0.048) and social (p=0.032), body
image (p=0.046) and respiration (p=0.028) HRQOL domains on the CFQ-R were also found in
the RTG.</p><table-wrap id="T1" position="float"><label>Table-I</label><caption><p>Effect of resistance training on pulmonary function, anthropometry &#x00026;
quality of life in patients with cystic fibrosis.</p></caption><table frame="hsides" rules="groups" width="100%"><thead><tr><th align="left" rowspan="1" colspan="1"/><th align="center" colspan="2" rowspan="1"><italic>Resistance Training Group (RTG)
(n=7)</italic></th><th align="center" colspan="2" rowspan="1"><italic>Non-Exercising Control Group (CON)
(n=4)</italic></th></tr><tr><th align="center" colspan="5" rowspan="1"><hr/></th></tr><tr><th align="left" rowspan="1" colspan="1"/><th align="left" rowspan="1" colspan="1"><italic>Pre-test</italic></th><th align="left" rowspan="1" colspan="1"><italic>Post-test</italic></th><th align="left" rowspan="1" colspan="1"><italic>Pre-test</italic></th><th align="left" rowspan="1" colspan="1"><italic>Post-test</italic></th></tr></thead><tbody><tr><td align="left" colspan="5" rowspan="1">ANTHROPOMETRY</td></tr><tr><td align="left" rowspan="1" colspan="1">Body mass (kg)</td><td align="left" rowspan="1" colspan="1">53.76&#x000b1;13.19</td><td align="left" rowspan="1" colspan="1">53.90&#x000b1;13.12</td><td align="left" rowspan="1" colspan="1">64.25&#x000b1;30.71</td><td align="left" rowspan="1" colspan="1">64.50&#x000b1;29.13</td></tr><tr><td align="left" rowspan="1" colspan="1">% Body fat (%)</td><td align="left" rowspan="1" colspan="1">15.51&#x000b1;5.78</td><td align="left" rowspan="1" colspan="1">16.51&#x000b1;5.98</td><td align="left" rowspan="1" colspan="1">18.12&#x000b1;11.38</td><td align="left" rowspan="1" colspan="1">18.05&#x000b1;10.82</td></tr><tr><td align="left" rowspan="1" colspan="1">Lean mass (kg)</td><td align="left" rowspan="1" colspan="1">49.60&#x000b1;7.71</td><td align="left" rowspan="1" colspan="1">44.99&#x000b1;9.80</td><td align="left" rowspan="1" colspan="1">50.28&#x000b1;19.31</td><td align="left" rowspan="1" colspan="1">50.65&#x000b1;17.49</td></tr><tr><td align="left" rowspan="1" colspan="1">Fat mass (kg)</td><td align="left" rowspan="1" colspan="1">8.61&#x000b1;4.65</td><td align="left" rowspan="1" colspan="1">8.87&#x000b1;4.77</td><td align="left" rowspan="1" colspan="1">13.95&#x000b1;12.49</td><td align="left" rowspan="1" colspan="1">14.10&#x000b1;11.86</td></tr><tr><td align="left" colspan="5" rowspan="1">SPIROMETRY</td></tr><tr><td align="left" rowspan="1" colspan="1">FEV<sub>1</sub> (&#x02113;.sec<sup>-1</sup>)</td><td align="left" rowspan="1" colspan="1">1.53&#x000b1;0.72</td><td align="left" rowspan="1" colspan="1">1.96&#x000b1;1.15<xref ref-type="table-fn" rid="t1f1">*</xref></td><td align="left" rowspan="1" colspan="1">2.43&#x000b1;0.92</td><td align="left" rowspan="1" colspan="1">2.50&#x000b1;1.05<xref ref-type="table-fn" rid="t1f2">&#x02020;</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">FVC (&#x02113;.sec<sup>-1</sup>)</td><td align="left" rowspan="1" colspan="1">2.53&#x000b1;0.86</td><td align="left" rowspan="1" colspan="1">2.78&#x000b1;1.20</td><td align="left" rowspan="1" colspan="1">3.70&#x000b1;1.47</td><td align="left" rowspan="1" colspan="1">3.62&#x000b1;1.50</td></tr><tr><td align="left" rowspan="1" colspan="1">FEV<sub>1</sub>/FVC</td><td align="left" rowspan="1" colspan="1">58.27&#x000b1;13.00</td><td align="left" rowspan="1" colspan="1">63.26&#x000b1;15.61<xref ref-type="table-fn" rid="t1f1">*</xref></td><td align="left" rowspan="1" colspan="1">67.20&#x000b1;10.40</td><td align="left" rowspan="1" colspan="1">68.70&#x000b1;5.64<xref ref-type="table-fn" rid="t1f2">&#x02020;</xref></td></tr><tr><td align="left" colspan="5" rowspan="1">ABDOMINAL AND THORACIC KINEMATICS</td></tr><tr><td align="left" rowspan="1" colspan="1">Resting chest (cm)</td><td align="left" rowspan="1" colspan="1">83.60&#x000b1;11.59</td><td align="left" rowspan="1" colspan="1">82.57&#x000b1;10.47</td><td align="left" rowspan="1" colspan="1">88.50&#x000b1;16.92</td><td align="left" rowspan="1" colspan="1">85.88&#x000b1;18.92</td></tr><tr><td align="left" rowspan="1" colspan="1">Chest inspiration (cm)</td><td align="left" rowspan="1" colspan="1">87.00&#x000b1;12.86</td><td align="left" rowspan="1" colspan="1">85.57&#x000b1;9.62</td><td align="left" rowspan="1" colspan="1">88.10&#x000b1;10.47</td><td align="left" rowspan="1" colspan="1">89.23&#x000b1;18.69</td></tr><tr><td align="left" rowspan="1" colspan="1">Chest expiration (cm)</td><td align="left" rowspan="1" colspan="1">82.33&#x000b1;18.58</td><td align="left" rowspan="1" colspan="1">81.06&#x000b1;10.09</td><td align="left" rowspan="1" colspan="1">90.67&#x000b1;16.56</td><td align="left" rowspan="1" colspan="1">83.73&#x000b1;17.42</td></tr><tr><td align="left" colspan="5" rowspan="1">MUSCULAR STRENGTH</td></tr><tr><td align="left" rowspan="1" colspan="1">Latissimusdorsi (L) (mmHg)</td><td align="left" rowspan="1" colspan="1">50.57&#x000b1;16.44</td><td align="left" rowspan="1" colspan="1">77.71&#x000b1;30.32<xref ref-type="table-fn" rid="t1f1">*</xref></td><td align="left" rowspan="1" colspan="1">57.00&#x000b1;27.25</td><td align="left" rowspan="1" colspan="1">81.50&#x000b1;54.22<xref ref-type="table-fn" rid="t1f2">&#x02020;</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Latissimusdorsi (R) (mmHg)</td><td align="left" rowspan="1" colspan="1">44.00&#x000b1;23.21</td><td align="left" rowspan="1" colspan="1">80.29&#x000b1;25.68<xref ref-type="table-fn" rid="t1f1">*</xref></td><td align="left" rowspan="1" colspan="1">41.50&#x000b1;24.08</td><td align="left" rowspan="1" colspan="1">78.00&#x000b1;48.19<xref ref-type="table-fn" rid="t1f2">&#x02020;</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Pectoralis major: clavicular (L) (mmHg)</td><td align="left" rowspan="1" colspan="1">60.00&#x000b1;34.16</td><td align="left" rowspan="1" colspan="1">75.14&#x000b1;21.60<xref ref-type="table-fn" rid="t1f1">*</xref></td><td align="left" rowspan="1" colspan="1">52.50&#x000b1;36.01</td><td align="left" rowspan="1" colspan="1">96.75&#x000b1;53.25<xref ref-type="table-fn" rid="t1f2">&#x02020;</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Pectoralis major: clavicular (R) (mmHg)</td><td align="left" rowspan="1" colspan="1">59.14&#x000b1;31.81</td><td align="left" rowspan="1" colspan="1">75.14&#x000b1;23.60<xref ref-type="table-fn" rid="t1f1">*</xref></td><td align="left" rowspan="1" colspan="1">58.00&#x000b1;32.08</td><td align="left" rowspan="1" colspan="1">109.50&#x000b1;67.54<xref ref-type="table-fn" rid="t1f2">&#x02020;</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Pectoralis major : sternocostal (R) (mmHg)</td><td align="left" rowspan="1" colspan="1">82.57&#x000b1;34.25</td><td align="left" rowspan="1" colspan="1">102.57&#x000b1;25.16<xref ref-type="table-fn" rid="t1f1">*</xref></td><td align="left" rowspan="1" colspan="1">74.50&#x000b1;48.51</td><td align="left" rowspan="1" colspan="1">80.50&#x000b1;42.34<xref ref-type="table-fn" rid="t1f2">&#x02020;</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Pectoralis major: sternocostal (R) (mmHg)</td><td align="left" rowspan="1" colspan="1">89.43&#x000b1;40.16</td><td align="left" rowspan="1" colspan="1">109.14&#x000b1;28.47<xref ref-type="table-fn" rid="t1f1">*</xref></td><td align="left" rowspan="1" colspan="1">76.50&#x000b1;40.61</td><td align="left" rowspan="1" colspan="1">102.50&#x000b1;68.50<xref ref-type="table-fn" rid="t1f2">&#x02020;</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Pectoralis minor (L) (mmHg)</td><td align="left" rowspan="1" colspan="1">75.14&#x000b1;56.35</td><td align="left" rowspan="1" colspan="1">64.29&#x000b1;24.64<xref ref-type="table-fn" rid="t1f1">*</xref></td><td align="left" rowspan="1" colspan="1">41.00&#x000b1;15.19</td><td align="left" rowspan="1" colspan="1">66.50&#x000b1;36.78<xref ref-type="table-fn" rid="t1f1">*</xref><xref ref-type="table-fn" rid="t1f2">&#x02020;</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Pectoralis minor (R) (mmHg)</td><td align="left" rowspan="1" colspan="1">74.29&#x000b1;49.95</td><td align="left" rowspan="1" colspan="1">69.14&#x000b1;20.03</td><td align="left" rowspan="1" colspan="1">45.00&#x000b1;21.57</td><td align="left" rowspan="1" colspan="1">63.50&#x000b1;25.42<xref ref-type="table-fn" rid="t1f1">*</xref><xref ref-type="table-fn" rid="t1f2">&#x02020;</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Seven-stage abdominal test</td><td align="left" rowspan="1" colspan="1">1.29&#x000b1;1.38</td><td align="left" rowspan="1" colspan="1">1.57&#x000b1;1.13</td><td align="left" rowspan="1" colspan="1">3.00&#x000b1;2.45</td><td align="left" rowspan="1" colspan="1">2.01&#x000b1;0.82<xref ref-type="table-fn" rid="t1f1">*</xref><xref ref-type="table-fn" rid="t1f2">&#x02020;</xref></td></tr><tr><td align="left" colspan="5" rowspan="1">QUALITY OF LIFE</td></tr><tr><td align="left" rowspan="1" colspan="1">Physical (<xref ref-type="table-fn" rid="t1f3">#</xref>)</td><td align="left" rowspan="1" colspan="1">38.88&#x000b1;28.86</td><td align="left" rowspan="1" colspan="1">42.06&#x000b1;21.96</td><td align="left" rowspan="1" colspan="1">65.28&#x000b1;44.99</td><td align="left" rowspan="1" colspan="1">44.44&#x000b1;22.68<xref ref-type="table-fn" rid="t1f1">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Emotional (<xref ref-type="table-fn" rid="t1f3">#</xref>)</td><td align="left" rowspan="1" colspan="1">39.28&#x000b1;26.99</td><td align="left" rowspan="1" colspan="1">48.81&#x000b1;5.22<xref ref-type="table-fn" rid="t1f1">*</xref></td><td align="left" rowspan="1" colspan="1">66.66&#x000b1;20.69</td><td align="left" rowspan="1" colspan="1">43.76&#x000b1;5.39<xref ref-type="table-fn" rid="t1f1">*</xref><xref ref-type="table-fn" rid="t1f2">&#x02020;</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Social (<xref ref-type="table-fn" rid="t1f3">#</xref>)</td><td align="left" rowspan="1" colspan="1">57.14&#x000b1;27.22</td><td align="left" rowspan="1" colspan="1">44.21&#x000b1;15.96<xref ref-type="table-fn" rid="t1f1">*</xref></td><td align="left" rowspan="1" colspan="1">69.05&#x000b1;29.74</td><td align="left" rowspan="1" colspan="1">64.28&#x000b1;21.47</td></tr><tr><td align="left" rowspan="1" colspan="1">Body image (<xref ref-type="table-fn" rid="t1f3">#</xref>)</td><td align="left" rowspan="1" colspan="1">65.07&#x000b1;26.00</td><td align="left" rowspan="1" colspan="1">46.03&#x000b1;23.51<xref ref-type="table-fn" rid="t1f1">*</xref></td><td align="left" rowspan="1" colspan="1">66.66&#x000b1;24.00</td><td align="left" rowspan="1" colspan="1">41.66&#x000b1;10.64<xref ref-type="table-fn" rid="t1f1">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Eating (<xref ref-type="table-fn" rid="t1f3">#</xref>)</td><td align="left" rowspan="1" colspan="1">49.20&#x000b1;12.60</td><td align="left" rowspan="1" colspan="1">46.03&#x000b1;25.20</td><td align="left" rowspan="1" colspan="1">63.88&#x000b1;21.03</td><td align="left" rowspan="1" colspan="1">25.00&#x000b1;29.22<xref ref-type="table-fn" rid="t1f1">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Treatment Burden (<xref ref-type="table-fn" rid="t1f3">#</xref>)</td><td align="left" rowspan="1" colspan="1">60.31&#x000b1;29.29</td><td align="left" rowspan="1" colspan="1">55.55&#x000b1;18.14</td><td align="left" rowspan="1" colspan="1">58.33&#x000b1;33.18</td><td align="left" rowspan="1" colspan="1">52.77&#x000b1;13.98</td></tr><tr><td align="left" rowspan="1" colspan="1">Respiration (<xref ref-type="table-fn" rid="t1f3">#</xref>)</td><td align="left" rowspan="1" colspan="1">52.38&#x000b1;26.66</td><td align="left" rowspan="1" colspan="1">33.33&#x000b1;15.21<xref ref-type="table-fn" rid="t1f1">*</xref></td><td align="left" rowspan="1" colspan="1">64.58&#x000b1;17.18</td><td align="left" rowspan="1" colspan="1">35.42&#x000b1;26.68<xref ref-type="table-fn" rid="t1f1">*</xref></td></tr><tr><td align="left" rowspan="1" colspan="1">Digestion (<xref ref-type="table-fn" rid="t1f3">#</xref>)</td><td align="left" rowspan="1" colspan="1">52.38&#x000b1;32.53</td><td align="left" rowspan="1" colspan="1">71.43&#x000b1;29.99<xref ref-type="table-fn" rid="t1f1">*</xref></td><td align="left" rowspan="1" colspan="1">75.00&#x000b1;16.67</td><td align="left" rowspan="1" colspan="1">91.67&#x000b1;16.67<xref ref-type="table-fn" rid="t1f1">*</xref></td></tr></tbody></table><table-wrap-foot><fn><p>Values are means&#x000b1;standard deviation;</p></fn><fn id="t1f1"><label>*</label><p>p&#x02264;0.05 compared to pre-test;</p></fn><fn id="t1f2"><label>&#x02020;</label><p>p &#x02264; 0.05 resistance training group (RTG) compared to non-exercising
control group (CON) kg: kilograms; %: percent; BMI:FEV<sub>1</sub>:
Forced expiratory volume in one second; FVC: Forced vital
capacity;&#x02113;.sec-1: litres per second; cm: centimeters; R: right; L: left;
mmHg: millimeters mercury;</p></fn><fn id="t1f3"><label>#</label><p>is the score out of 100 (100 being the highest score possible and 0 being the
lowest).</p></fn></table-wrap-foot></table-wrap><p>In the CON, pectoralis minor strength on the left (p=0.034) and right (p=0.042), and the
digestion (p=0.026) HRQOL domain on the CFQ-R increased significantly following the
experimental period. In addition, the CON displayed significant decreases in physical
(p=0.029), emotional (p=0.030), body image (p=0.036), eating (p=0.008) and respiration
(p=0.018) HRQOL domains on the CFQ-R.</p><p>Results also indicated that FEV<sub>1</sub> (p=0.041), FEV<sub>1</sub>/FVC (p=0.032),
latissimusdorsi strength on the left (p=0.047), pectoralis major: sternocostal portion
on the right (p=0.025), pectoralis minor strength on the left (p=0.011) and right
(p=0.020), seven-stage abdominal test (p=0.001) and emotional (p&#x0003c;0.001) HRQOL
domain on the CFQ-R were significantly different at post-test when comparing the RTG and
CON.</p></sec><sec sec-type="discussion" id="sec1-4"><title>DISCUSSION</title><p>From infancy, CF patients are subjected to numerous stressful and/or time-consuming
treatments, such as inhalation therapy, mist tents, suction machines, exercise-based
rehabilitation and nebulization.<xref rid="ref2" ref-type="bibr">2</xref> Specifically
relating to exercise-based rehabilitation, aerobic exercise training is a commonly used
approach for improving physical capacity and HRQOL in pulmonary rehabilitation
programs.<xref rid="ref21" ref-type="bibr">21</xref> However, since dyspnea limits
exercise adherence and intensity in lung patients, the use of RT may be warranted in
this population. This is because RT results in less dyspnea than other forms of
exercise. In addition, the concomitant use RT during nebulization times may result in
improvements in both the efficacy of the nebulization, since RT may increase the dwell
time of the inhaled submicronic particles as a result of Valsalva maneuvers, and the
enhanced efficacy of the nebulized medications may reduce exercise-induced hypoxemia and
increase exercise tolerance, oxygen supply and adaptations and thus overcome the primary
reason that many CF patients abstain from exercise and enhance long-term
adaptations.</p><p>In this regard, this study has demonstrated that RT during nebulization times provides
simultaneous benefits in spirometry, muscle strength and QOL. The improvements in
spirometry in this study, especially considering the short duration of the exercise
program, are noteworthy since increases in spirometry in lung patients following
exercise training are generally uncommon<xref rid="ref19" ref-type="bibr">19</xref>,
even in CF patients.<xref rid="ref22" ref-type="bibr">22</xref> However, since
FEV<sub>1</sub> is considered an effort-/force-/muscle-dependent variable, any
improvements in respiratory muscle strength, as also found in this study, are also
likely to result in improvements in lung function.<xref rid="ref23" ref-type="bibr">23</xref> Although few data exist on the effect of exercise on respiratory muscle
function in patients with CF,<xref rid="ref24" ref-type="bibr">24</xref> the present
study demonstrated that a RT program can improve the strength of the accessory muscles
of respiration needed when an individual breathes in at the maximal flow rate.</p><p>Following a period of RT, the present study found increases in the emotional and
digestion domains on the CFQ-R. This is a novel finding in that quality of life has only
previously been correlated with an individual&#x02019;s aerobic capacity.<xref rid="ref25" ref-type="bibr">25</xref> However, it must be noted that social, body
image and respiration domains of HRQOL decreased following the RT. Despite an
improvement in the emotional domain, the decrease in the social domain is not entirely
unanticipated in that depressive symptoms are common in individuals with CF<xref rid="ref25" ref-type="bibr">25</xref> and further investigation is warranted on the
effect of RT on mood state and psychological domains of HRQOL. While the finding on the
respiration domain is not congruent with the findings regarding spirometry, the finding
on the body image domain is not unexpected considering that the experimental group did
not demonstrate any improvements in body composition following the exercise training.
This is a unique finding in that previously, research has demonstrated that RT does not
improve HRQOL in children with CF.<xref rid="ref1" ref-type="bibr">1</xref></p><p>However, caution must be heeded that the results of this study cannot be generalized to
all patients with CF since the convenience sample of 14 is too small (even though it
made use of a control group) to reach a definitive conclusion and the CON and RTG
baseline values, especially spirometry and HRQOL, may be negatively correlated with
change since the RTG patients with low scores at baseline would typically improve more
than those with high scores. In addition, the study found simultaneous improvements and
decreases in some measures warranting the need for further research. These future
studies should utilize longer durations of exercise-based rehabilitation especially when
evaluating HRQOL.</p></sec><sec sec-type="conclusion" id="sec1-5"><title>CONCLUSION</title><p>These results of this small scale proof-of-concept investigation suggest that CF
patients should undertake regular RT during nebulization to ensure higher indices of
pulmonary function, respiratory muscle strength and some aspects of HRQOL. This study
also highlights the importance of respiratory muscular strength development in this
population, considering that improvements in spirometry are generally uncommon in CF
patients following exercise training. This study potentially provides an effective
alternative, time-saving treatment for the CF patient that does not add to the treatment
burden.</p></sec></body><back><fn-group><fn fn-type="financial-disclosure"><p><bold><italic>Grant Support and Financial Disclosures:</italic></bold> None</p></fn></fn-group><sec id="sec1-6"><title/><sec id="sec2-1"><title>Author&#x02019;s Contribution</title><p><bold>IS, JEK, RR &#x00026; BSS</bold> contributed to the conception &#x00026;
design,</p><p><bold>JEK, RR</bold> contributed to the acquisition of data,</p><p><bold>IS &#x00026; BSS</bold> contributed to the analysis &#x00026; interpretation of
data,</p><p><bold>IS, JEK, RR &#x00026; BSS</bold> participated in drafting the article</p><p><bold>IS &#x00026; BSS</bold> revised the article critically for important
intellectual content</p><p><bold>IS, JEK, RR &#x00026; BSS</bold> gave final approval of the version to be
submitted.</p></sec></sec><ref-list><title>REFERENCES</title><ref id="ref1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Orenstein</surname><given-names>DM</given-names></name><name><surname>Winnie</surname><given-names>GB</given-names></name><name><surname>Altman</surname><given-names>H</given-names></name></person-group><article-title>Cystic fibrosis:A 2002 update</article-title><source>J Pediatr</source><year>2002</year><volume>140</volume><fpage>156</fpage><lpage>164</lpage><comment>doi:10.1067/mpd.2002.120269 </comment><pub-id pub-id-type="pmid">11865265</pub-id></element-citation></ref><ref id="ref2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Novinger</surname><given-names>AM</given-names></name></person-group><article-title>A school nurse looks at cystic fibrosis</article-title><source>J School Health</source><year>1973</year><volume>43</volume><fpage>515</fpage><lpage>520</lpage><comment>doi:10.1111/j.1746-1561.1973.tb03745.x</comment><pub-id pub-id-type="pmid">4490489</pub-id></element-citation></ref><ref id="ref3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Conway</surname><given-names>SP</given-names></name></person-group><article-title>Evidence for using nebulised antibiotics in cystic
fibrosis</article-title><source>Arch Dis Child</source><year>1999</year><volume>80</volume><fpage>307</fpage><lpage>309</lpage><comment>doi:10.1136/adc.80.4.307</comment><pub-id pub-id-type="pmid">10086931</pub-id></element-citation></ref><ref id="ref4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Collins</surname><given-names>N</given-names></name></person-group><article-title>Nebulizer therapy in cystic fibrosis:An overview</article-title><source>J R Soc Med</source><year>2009</year><volume>102</volume><issue>Suppl 1</issue><fpage>11</fpage><lpage>17</lpage><comment>doi:10.1258/jrsm.2009.s19003 </comment></element-citation></ref><ref id="ref5"><label>5</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Zanen</surname><given-names>P</given-names></name><name><surname>Laube</surname><given-names>B</given-names></name></person-group><person-group person-group-type="editor"><name><surname>Bisgaard</surname><given-names>H</given-names></name><name><surname>O&#x02019;Callaghan</surname><given-names>C</given-names></name><name><surname>Smalldone</surname><given-names>G</given-names></name></person-group><article-title>Targeting the lungs with therapeutic aerosols</article-title><source>Drug delivery to the lung</source><year>2002</year><publisher-loc>New York, NY</publisher-loc><publisher-name>Marcel Dekker</publisher-name><fpage>211</fpage><lpage>268</lpage></element-citation></ref><ref id="ref6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McKone</surname><given-names>E</given-names></name><name><surname>Barry</surname><given-names>S</given-names></name><name><surname>FitzGerald</surname><given-names>M</given-names></name><name><surname>Gallagher</surname><given-names>C</given-names></name></person-group><article-title>The role of supplemental oxygen during submaximal exercise in patients
with cystic fibrosis</article-title><source>EurRespir J</source><year>2002</year><volume>20</volume><issue>1</issue><fpage>134</fpage><lpage>142</lpage><comment>doi:10.1183/09031936.02.00492001 </comment></element-citation></ref><ref id="ref7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iepsen</surname><given-names>UW</given-names></name><name><surname>J&#x000f8;rgensen</surname><given-names>KJ</given-names></name><name><surname>Ringbaek</surname><given-names>T</given-names></name><name><surname>Hansen</surname><given-names>H</given-names></name><name><surname>Skrubbeltrang</surname><given-names>C</given-names></name><name><surname>Lange</surname><given-names>P</given-names></name></person-group><article-title>A systematic review of resistance training versus endurance training
in COPD</article-title><source>J Cardiopulm Rehabil Prev</source><year>2015</year><volume>35</volume><issue>3</issue><fpage>163</fpage><lpage>172</lpage><comment>doi:10.1097/HCR.0000000000000105 </comment><pub-id pub-id-type="pmid">25692720</pub-id></element-citation></ref><ref id="ref8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kabra</surname><given-names>SK</given-names></name><name><surname>Kabra</surname><given-names>M</given-names></name><name><surname>Shastri</surname><given-names>S</given-names></name><name><surname>Lodha</surname><given-names>R</given-names></name></person-group><article-title>Diagnosing &#x00026;managing cystic fibrosis in the developing
world</article-title><source>Pediatr Respir Rev</source><year>2006</year><volume>7</volume><issue>Suppl 1</issue><fpage>S147</fpage><lpage>S150</lpage><comment>doi:10.1016/j.prrv.2006.04.218 </comment></element-citation></ref><ref id="ref9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Quittner</surname><given-names>AL</given-names></name><name><surname>Buu</surname><given-names>A</given-names></name><name><surname>Messer</surname><given-names>MA</given-names></name><name><surname>Modi</surname><given-names>AC</given-names></name><name><surname>Watrous</surname><given-names>M</given-names></name></person-group><article-title>Development &#x00026; Validation of The Cystic Fibrosis Questionnaire
in the United States:A health-related quality-of-life measure for cystic
fibrosis</article-title><source>Chest</source><year>2005</year><volume>128</volume><issue>4</issue><fpage>2347</fpage><lpage>2354</lpage><comment>doi:10.1378/chest.128.4.2347</comment><pub-id pub-id-type="pmid">16236893</pub-id></element-citation></ref><ref id="ref10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Withers</surname><given-names>RT</given-names></name><name><surname>LaForgia</surname><given-names>J</given-names></name><name><surname>Pillans</surname><given-names>RK</given-names></name><name><surname>Shipp</surname><given-names>NJ</given-names></name><name><surname>Chatterton</surname><given-names>BE</given-names></name><name><surname>Schultz</surname><given-names>CG</given-names></name><etal/></person-group><article-title>Comparisons of two-, three-, and four-compartment models of body
composition analysis in men and women</article-title><source>J Appl Physiol</source><year>1998</year><volume>85</volume><fpage>238</fpage><lpage>245</lpage><pub-id pub-id-type="pmid">9655781</pub-id></element-citation></ref><ref id="ref11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shaw</surname><given-names>BS</given-names></name><name><surname>Shaw</surname><given-names>I</given-names></name><name><surname>Mamen</surname><given-names>A</given-names></name></person-group><article-title>Contrasting effects in anthropometric measures of total fatness
&#x00026; abdominal fat mass following endurance &#x00026; concurrent endurance
&#x00026;resistance training</article-title><source>J Sports Med Phys Fitness</source><year>2010</year><volume>50</volume><issue>2</issue><fpage>207</fpage><lpage>213</lpage><pub-id pub-id-type="pmid">20585300</pub-id></element-citation></ref><ref id="ref12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Miller</surname><given-names>M</given-names></name><name><surname>Hankinson</surname><given-names>J</given-names></name><name><surname>Brusasco</surname><given-names>V</given-names></name><name><surname>Burgos</surname><given-names>F</given-names></name><name><surname>Casaburi</surname><given-names>R</given-names></name><name><surname>Coates</surname><given-names>A</given-names></name><etal/></person-group><article-title>Standardization of spirometry</article-title><source>Eur Respir J</source><year>2005</year><volume>26</volume><issue>2</issue><fpage>319</fpage><lpage>338</lpage><comment>doi:10.1183/09031936.05.00034805</comment><pub-id pub-id-type="pmid">16055882</pub-id></element-citation></ref><ref id="ref13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shaw</surname><given-names>BS</given-names></name><name><surname>Shaw</surname><given-names>I</given-names></name></person-group><article-title>Pulmonary function &#x00026; abdominal &#x00026; thoracic kinematic
changes following aerobic &#x00026; inspiratory resistive diaphragmatic breathing
training in asthmatics</article-title><source>Lung</source><year>2011</year><volume>189</volume><issue>2</issue><fpage>131</fpage><lpage>139</lpage><comment>doi:10.1007/s00408-011-9281-8 </comment><pub-id pub-id-type="pmid">21318637</pub-id></element-citation></ref><ref id="ref14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perez</surname><given-names>T</given-names></name></person-group><article-title>Neuromuscular disorders - assessment of the respiratory
muscles</article-title><source>Revue Neurologique</source><year>2006</year><volume>162</volume><issue>4</issue><fpage>437</fpage><lpage>444</lpage><comment>doi:10.1016/S0035-3787(06)75034-2 </comment><pub-id pub-id-type="pmid">16585904</pub-id></element-citation></ref><ref id="ref15"><label>15</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Kendall</surname><given-names>F</given-names></name><name><surname>McCreary</surname><given-names>E</given-names></name><name><surname>Provance</surname><given-names>P</given-names></name><name><surname>Rodgers</surname><given-names>M</given-names></name><name><surname>Romani</surname><given-names>W</given-names></name></person-group><source>Muscle testing &#x00026; function with posture &#x00026; pain</source><year>2005</year><edition>Fifth edition</edition><publisher-loc>Baltimore, MD</publisher-loc><publisher-name>LWW</publisher-name></element-citation></ref><ref id="ref16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gildenhuys</surname><given-names>GM</given-names></name><name><surname>Fourie</surname><given-names>M</given-names></name><name><surname>Shaw</surname><given-names>I</given-names></name><name><surname>Shaw</surname><given-names>BS</given-names></name><name><surname>Toriola</surname><given-names>AL</given-names></name></person-group><article-title>A randomised controlled study investigating pulmonary function
&#x00026;respiratory muscle strength in older adults after training with
Pilates</article-title><source>Afri J Phys Health Educ Rec Dance</source><year>2013</year><issue>Suppl 1</issue><fpage>194</fpage><lpage>203</lpage></element-citation></ref><ref id="ref17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schneiderman-Walker</surname><given-names>J</given-names></name><name><surname>Pollock</surname><given-names>SL</given-names></name><name><surname>Corey</surname><given-names>M</given-names></name><name><surname>Wilkes</surname><given-names>DD</given-names></name><name><surname>Canny</surname><given-names>GJ</given-names></name><name><surname>Pedder</surname><given-names>L</given-names></name><etal/></person-group><article-title>A randomized controlled trial of a 3-year home exercise program in
cystic fibrosis</article-title><source>J Pediatr</source><year>2000</year><volume>136</volume><issue>3</issue><fpage>304</fpage><lpage>310</lpage><comment>doi:10.1067/mpd.2000.103408</comment><pub-id pub-id-type="pmid">10700685</pub-id></element-citation></ref><ref id="ref18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ramos</surname><given-names>EM</given-names></name><name><surname>de Toledo-Arruda</surname><given-names>AC</given-names></name><name><surname>Fosco</surname><given-names>LC</given-names></name><name><surname>Bonfim</surname><given-names>R</given-names></name><name><surname>Bertolini</surname><given-names>GN</given-names></name><name><surname>Guarnier</surname><given-names>FA</given-names></name><etal/></person-group><article-title>The effects of elastic tubing-based resistance training compared with
conventional resistance training in patients with moderate chronic obstructive
pulmonary disease:A randomized clinical trial</article-title><source>ClinRehabil</source><year>2014</year><volume>28</volume><issue>11</issue><fpage>1096</fpage><lpage>1106</lpage><comment>doi:10.1177/0269215514527842</comment></element-citation></ref><ref id="ref19"><label>19</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moorcroft</surname><given-names>AJ</given-names></name><name><surname>Dodd</surname><given-names>ME</given-names></name><name><surname>Morris</surname><given-names>J</given-names></name><name><surname>Webb</surname><given-names>AK</given-names></name></person-group><article-title>Individualised unsupervised exercise training in adults with cystic
fibrosis:A 1 year randomised controlled trial</article-title><source>Thorax</source><year>2004</year><volume>59</volume><fpage>1074</fpage><lpage>1080</lpage><comment>doi:10.1136/thx.2003.015313 </comment><pub-id pub-id-type="pmid">15563708</pub-id></element-citation></ref><ref id="ref20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kaminski</surname><given-names>TW</given-names></name><name><surname>Buckley</surname><given-names>BD</given-names></name><name><surname>Powers</surname><given-names>ME</given-names></name><name><surname>Hubbard</surname><given-names>TJ</given-names></name><name><surname>Ortiz</surname><given-names>C</given-names></name></person-group><article-title>Effect of strength &#x00026;proprioception training on eversion to
inversion strength ratios in subjects with unilateral functional ankle
instability</article-title><source>Br J Sports Med</source><year>2003</year><volume>37</volume><fpage>410</fpage><lpage>415</lpage><comment>doi:10.1136/bjsm.37.5.410</comment><pub-id pub-id-type="pmid">14514531</pub-id></element-citation></ref><ref id="ref21"><label>21</label><element-citation publication-type="journal"><collab>American College of Chest Physicians &#x00026;American Association of
Cardiovascular &#x00026; Pulmonary Rehabilitation</collab><article-title>Pulmonary rehabilitation:joint ACCP/AACVPR evidence-based guidelines.
ACCP/AACVPR Pulmonary Rehabilitation Guidelines Panel</article-title><source>Chest</source><year>1997</year><volume>112</volume><issue>5</issue><fpage>1363</fpage><lpage>1396</lpage><comment>doi:10.1378/chest.112.5.1363</comment><pub-id pub-id-type="pmid">9367481</pub-id></element-citation></ref><ref id="ref22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Strauss</surname><given-names>GD</given-names></name><name><surname>Osher</surname><given-names>A</given-names></name><name><surname>Wang</surname><given-names>CI</given-names></name><name><surname>Goodrich</surname><given-names>E</given-names></name><name><surname>Gold</surname><given-names>F</given-names></name><name><surname>Colman</surname><given-names>W</given-names></name><etal/></person-group><article-title>Variable weight training in cystic fibrosis</article-title><source>Chest</source><year>1987</year><volume>92</volume><issue>2</issue><fpage>273</fpage><lpage>276</lpage><comment>doi:10.1378/chest.92.2.273 </comment><pub-id pub-id-type="pmid">3608598</pub-id></element-citation></ref><ref id="ref23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shaw</surname><given-names>BS</given-names></name><name><surname>Shaw</surname><given-names>I</given-names></name></person-group><article-title>Response of pulmonary peak flow measures to upper body resistance
training</article-title><source>Afri J Phys Health Educ Rec Dance</source><year>2005</year><volume>11</volume><issue>1</issue><fpage>39</fpage><lpage>50</lpage></element-citation></ref><ref id="ref24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dassios</surname><given-names>T</given-names></name><name><surname>Katelari</surname><given-names>A</given-names></name><name><surname>Doudounakis</surname><given-names>S</given-names></name><name><surname>Dimitriou</surname><given-names>G</given-names></name></person-group><article-title>Aerobic exercise &#x00026;respiratory muscle strength in patients with
cystic fibrosis</article-title><source>Respir Med</source><year>2013</year><volume>107</volume><issue>5</issue><fpage>684</fpage><lpage>690</lpage><comment>doi:10.1016/j.rmed.2013.01.016 </comment><pub-id pub-id-type="pmid">23485096</pub-id></element-citation></ref><ref id="ref25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schmidt</surname><given-names>AM</given-names></name><name><surname>Jacobsen</surname><given-names>U</given-names></name><name><surname>Bregnballe</surname><given-names>V</given-names></name><name><surname>Olesen</surname><given-names>H</given-names></name><name><surname>Ingemann-Hansen</surname><given-names>T</given-names></name><name><surname>Thastum</surname><given-names>M</given-names></name><etal/></person-group><article-title>Exercise &#x00026;quality of life in patients with cystic fibrosis:A
12-week intervention study</article-title><source>Physiother Theory Pract</source><year>2010</year><volume>27</volume><issue>8</issue><fpage>548</fpage><lpage>556</lpage><comment>doi:10.3109/09593985.2010.545102 </comment></element-citation></ref></ref-list></back></article>